June 2026– date –
-
FUJIFILM Completes £400M UK Teesside CDMO Expansion, Accelerating Bioprocess Innovation and Cell Product Diversification
Fujifilm Japan Overview FUJIFILM announced significant life sciences advancements at BIO 2026, notably completing a £400 million investment in its UK Teesside manufacturing facility, making it the largest single-use CDMO site in the coun... -
Ernexa Therapeutics Accelerates iPSC-Derived MSC Manufacturing with Japan JEAP Selection, Highlighting Japan’s CDMO Ecosystem as Key
Clinical Leader USA Overview Ernexa Therapeutics has been selected for Japan's Entry Acceleration Program (JEAP), gaining a critical opportunity to advance its induced pluripotent stem cell (iPSC)-derived mesenchymal stem cell (iMSC) pla... -
U.S. Stem Cell Manufacturing Market Forecast to Reach $4.04 Billion, Driven by Innovative Technologies and Automation from Thermo Fisher, Lonza, and Sartorius
openPR.com USA Overview This article summarizes a report on the U.S. stem cell manufacturing market, projected to reach $4.04 billion, driven by innovative technologies and strategic initiatives from key players. Thermo Fisher Scientific... -
WuXi Biologics Suzhou BioSafety Testing Center Secures Fourth EMA GMP Certification, Enabling 19 Commercial Products for European Market
WuXi Biologics China Overview WuXi Biologics' Suzhou BioSafety Testing Center has successfully renewed its European Medicines Agency (EMA) GMP certification for the fourth time. This accreditation enables the center to support quality te... -
Advancing Cell Therapy Production: CCRM, OmniaBio, and Avectas Pioneer Automated Hub-and-Spoke Model for CAR-T, iPSC, and Lentiviral Vectors
PR Newswire (CCRM) Canada, アイルランド Overview CCRM and its CDMO subsidiary, OmniaBio, have partnered with Avectas Limited to evaluate an automated, integrated, and scalable cell therapy manufacturing platform. This strategic alliance ... -
Sartorius Revolutionizes Protein Production with Rational CHO Host Cell Engineering: Maximizing Intrinsic Expression Capacity
BioProcess International (Sartorius) Germany Overview Sartorius presented a webcast on rational CHO (Chinese Hamster Ovary) host cell engineering, aiming to significantly boost protein production. Diverging from traditional optimization ... -
HTMP Biotechnology Unveils HTMP™ 192 High-Throughput Platform for 3D Cell Culture, Revolutionizing Drug Discovery and Disease Modeling
HTMP Biotechnology USA Overview HTMP Biotechnology has launched its "HTMP™ 192" high-throughput microwell platform, designed to enable stable 3D cell culture workflows, addressing the critical challenge of disturbing 3D cellular structur... -
Matica Biotechnology and Cirsium Biosciences Partner to Accelerate Flexible AAV Manufacturing via Matica Open Access Platform, Integrating Plant-Based Technology and Single-Use Innovations
BioSpace USA Overview Matica Biotechnology and Cirsium Biosciences announced the adoption of Matica's Open Access Platform to enhance flexibility, transparency, and scalability in Adeno-Associated Virus (AAV) development and manufacturin... -
Matica Biotechnology Launches Integrated Korea IIT Platform: Linking US Manufacturing with Korean Clinical Execution to Accelerate Advanced Therapy Development
PR Newswire (Matica Biotechnology) USA, South Korea Overview Matica Biotechnology has launched the 'Accelerated Matica Korea IIT Integrated Platform Solution,' designed to efficiently link U.S. manufacturing with clinical execution in So... -
ACS Publications Reviews Metabolomics-Guided Metabolite Production in Plant Tissue Culture: Integrating Omics and Synthetic Biology for Enhanced Yields
ACS Publications USA Overview A comprehensive review in ACS Publications focuses on metabolomics-guided metabolite production in plant tissue culture (PTC), aiming to enhance yields by integrating omics and synthetic biology. Key solutio...
